Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy
Condition(s):Extensive-stage Small Cell Lung Cancer; Lung CancerLast Updated:December 7, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Extensive-stage Small Cell Lung Cancer; Lung CancerLast Updated:December 7, 2017Unknown status
Condition(s):Oral MucositisLast Updated:May 26, 2014Unknown status
Condition(s):StomatitisLast Updated:July 27, 2023Completed
Condition(s):Metastatic Carcinoma of the CervixLast Updated:August 14, 2023Suspended
Condition(s):Muscle Invasive Bladder CancerLast Updated:September 26, 2019Unknown status
Condition(s):Advanced Gastric CancerLast Updated:May 20, 2015Completed
Condition(s):Urothelial CarcinomaLast Updated:November 21, 2017Completed
Condition(s):Squamous Cell Carcinoma of the Head and Neck; Squamous Cell CarcinomaLast Updated:January 13, 2022Terminated
Condition(s):Gastric Cancer; Gastroesophageal-junction Cancer; Advanced CancerLast Updated:October 23, 2023Not yet recruiting
Condition(s):Small Cell Lung CancerLast Updated:July 19, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.